
Tyler Van De Voort MD
Trauma Surgery & Surgical Critical Care
Trauma/Acute Care Surgeon
Join to View Full Profile
835 S Van Buren StGreen Bay, WI 54301
Phone+1 920-433-0111
Dr. Van De Voort is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Tyler Van De Voort, MD, is a general surgeon based in Green Bay, WI, with subspecialties in trauma surgery and surgical critical care. He completed a fellowship in surgical critical care at the University of Louisville School of Medicine in 2023 and a surgery residency at the University of North Dakota in 2022. He graduated from the University of Wisconsin School of Medicine & Public Health in 2017 and holds a BS in molecular biology and history from the University of Wisconsin-Madison. Currently, he is employed as a surgeon at Prevea Health. Dr. Van De Voort has co-authored several publications in immunotherapy and cancer research, with his work being cited multiple times in various scientific journals.
Education & Training
- University of Louisville School of MedicineFellowship, Surgical Critical Care, 2022 - 2023
- University of North DakotaResidency, Surgery, 2017 - 2022
- University of Wisconsin School of Medicine & Public HealthClass of 2017
- University of Wisconsin-MadisonBS, Molecular Biology and History, Comprehensive Honors, 2008 - 2012
Certifications & Licensure
- WI State Medical License 2023 - 2025
- KY State Medical License 2022 - 2024
- ND State Medical License 2017 - 2022
- MN State Medical License 2019 - 2019
- American Board of Surgery Surgery
- American Board of Surgery Surgical Critical Care
Publications & Presentations
PubMed
- 18 citationsEffective Combination of Innate and Adaptive Immunotherapeutic Approaches in a Mouse Melanoma Model.Alexander L. Rakhmilevich, Mildred Felder, Lauren Lever, Jacob Slowinski, Kayla Rasmussen
Journal of Immunology. 2017-02-15 - 24 citationsIntratumoral delivery of low doses of anti-CD40 mAb combined with monophosphoryl lipid a induces local and systemic antitumor effects in immunocompetent and T cell-def...Tyler J. Van De Voort, Mildred Felder, Richard K. Yang, Paul M. Sondel, Alexander L. Rakhmilevich
Journal of Immunotherapy. 2013-01-01 - 14 citationsTumor-associated myeloid cells can be activated in vitro and in vivo to mediate antitumor effectsAlexander L. Rakhmilevich, Mark J. Baldeshwiler, Tyler J. Van De Voort, Mildred Felder, Richard K. Yang
Cancer Immunology, Immunotherapy. 2012-03-06
Professional Memberships
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: